Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-13-003232
Accepted
2013-11-12 00:15:17
Documents
1
Effectiveness Date
2013-11-08
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-13-003232.txt   1779
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-191468 | Film No.: 131206267
SIC: 6770 Blank Checks